|
1
|
Viso E, Gude F and Rodríguez-Ares MT:
Prevalence of pinguecula and pterygium in a general population in
Spain. Eye (Lond). 25:350–7. 2011. View Article : Google Scholar
|
|
2
|
Achigbu E and Ezepue UF: Prevalence and
severity of pterygium among commercial motorcycle riders in South
Eastern Nigeria. Ghana Med J. 48:153–157. 2014. View Article : Google Scholar
|
|
3
|
Asokan R, Venkatasubbu RS, Velumuri L,
Lingam V and George R: Prevalence and associated factors for
pterygium and pinguecula in a South Indian population. Ophthalmic
Physiol Opt. 32:39–44. 2012. View Article : Google Scholar
|
|
4
|
Zhong H, Chen Q, Li J, Shen W, Sheng X,
Niu Z, Zhou H, Wei T, Yuan Y and Pan CW: Ethnic variations in
pterygium in a rural population in southwestern China: The Yunnan
minority eye studies. Ophthalmic Epidemiol. 23:116–121. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coroneo MT, Di Girolamo N and Wakefield D:
The pathogenesis of pterygia. Curr Opin Ophthalmol. 10:282–288.
1999. View Article : Google Scholar
|
|
6
|
Threlfall TJ and English DR: Sun exposure
and pterygium of the eye: a dose-response curve. Am J Ophthalmol.
128:280–287. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chui J, Di Girolamo N, Wakefield D and
Coroneo MT: The pathogenesis of pterygium: current concepts and
their therapeutic implications. Ocul Surf. 6:24–43. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Anguria P, Kitinya J, Ntuli S and
Carmichael T: The role of heredity in pterygium development. Int J
Ophthalmol. 7:563–573. 2014.PubMed/NCBI
|
|
9
|
Bianchi E, Scarinci F, Grande C, Plateroti
R, Plateroti P, Plateroti AM, Fumagalli L, Capozzi P, Feher J and
Artico M: Immunohistochemical profile of VEGF, TGF-β and
PGE2 in human pterygium and normal conjunctiva:
experimental study and review of the literature. Int J Immunopathol
Pharmacol. 25:607–615. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Young CH, Lo YL, Tsai YY, Shih TS, Lee H
and Cheng YW: CYP1A1 gene polymorphisms as a risk factor for
pterygium. Mol Vis. 16:1054–1058. 2010.PubMed/NCBI
|
|
11
|
Kria L, Ohira A and Amemiya T: Growth
factors in cultured pterygium fibroblasts: immunohistochemical and
ELISA analysis. Graefes Arch Clin Exp Ophthalmol. 236:702–708.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Powers MR, Qu Z, O'Brien B, Wilson DJ,
Thompson JE and Rosenbaum JT: Immunolocalization of bFGF in
pterygia: association with mast cells. Cornea. 16:545–549. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee DH, Cho HJ, Kim JT, Choi JS and Joo
CK: Expression of vascular endothelial growth factor and inducible
nitric oxide synthase in pterygia. Cornea. 20:738–742. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen JK, Tsai RJ and Lin SS: Fibroblasts
isolated from human pterygia exhibit transformed cell
characteristics. In Vitro Cell Dev Biol Anim. 30A:243–248. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maheshwari RK, Singh AK, Gaddipati J and
Srimal RC: Multiple biological activities of curcumin: a short
review. Life Sci. 78:2081–2087. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang N, Li H, Jia J and He M:
Anti-inflammatory effect of curcumin on mast cell-mediated allergic
responses in ovalbumin-induced allergic rhinitis mouse. Cell
Immunol. 298:88–95. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kunnumakkara AB, Anand P and Aggarwal BB:
Curcumin inhibits proliferation, invasion, angiogenesis and
metastasis of different cancers through interaction with multiple
cell signaling proteins. Cancer Lett. 269:199–225. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Collaborative Ocular Melanoma Study Group:
The COMS randomized trial of iodine 125 brachytherapy for choroidal
melanoma: V. Twelve-year mortality rates and prognostic factors:
COMS report No. 28. Arch Ophthalmol. 124:1684–1693. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bimonte S, Barbieri A, Palma G, Rea D,
Luciano A, D'Aiuto M, Arra C and Izzo F: Dissecting the role of
curcumin in tumour growth and angiogenesis in mouse model of human
breast cancer. BioMed Res Int. 2015:8781342015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Khan N and Mukhtar H: Dietary agents for
prevention and treatment of lung cancer. Cancer Lett. 359:155–164.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen A, Xu J and Johnson AC: Curcumin
inhibits human colon cancer cell growth by suppressing gene
expression of epidermal growth factor receptor through reducing the
activity of the transcription factor Egr-1. Oncogene. 25:278–287.
2006.
|
|
22
|
Gupta SC, Patchva S and Aggarwal BB:
Therapeutic roles of curcumin: lessons learned from clinical
trials. AAPS J. 15:195–218. 2013. View Article : Google Scholar :
|
|
23
|
Amin AR, Haque A, Rahman MA, Chen ZG,
Khuri FR and Shin DM: Curcumin induces apoptosis of upper
aerodigestive tract cancer cells by targeting multiple pathways.
PLoS One. 10:e01242182015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shi M, Cai Q, Yao L, Mao Y, Ming Y and
Ouyang G: Antiproliferation and apoptosis induced by curcumin in
human ovarian cancer cells. Cell Biol Int. 30:221–226. 2006.
View Article : Google Scholar
|
|
25
|
Hong JH, Ahn KS, Bae E, Jeon SS and Choi
HY: The effects of curcumin on the invasiveness of prostate cancer
in vitro and in vivo. Prostate Cancer Prostatic Dis. 9:147–152.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu C, Song E, Hu DN, Chen M, Xue C, Rosen
R and McCormick SA: Curcumin induces cell death in human uveal
melanoma cells through mitochondrial pathway. Curr Eye Res.
35:352–360. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang M, Bian F, Wen C and Hao N:
Inhibitory effect of curcumin on proliferation of human pterygium
fibroblasts. J Huazhong Univ Sci Technolog Med Sci. 27:339–342.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang SF, Lin CY, Yang PY, Chao SC, Ye YZ
and Hu DN: Increased expression of gelatinase (MMP-2 and MMP-9) in
pterygia and pterygium fibroblasts with disease progression and
activation of protein kinase C. Invest Ophthalmol Vis Sci.
50:4588–4596. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ribatti D, Nico B, Perra MT, Maxia C,
Piras F, Murtas D, Crivellato E and Sirigu P: Correlation between
NGF/TrkA and microvascular density in human pterygium. Int J Exp
Pathol. 90:615–620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dos Reis GM, de P R Júnior A, E Silva KS,
Rodrigues DA, Gomes MC, Martins JV, da Costa IR, Freitas GA and
Moura KK: Pterygium in patients from Goiânia, Goiás, Brazil. Genet
Mol Res. 14:6182–6188. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shehzad A, Lee J and Lee YS: Curcumin in
various cancers. Biofactors. 39:56–68. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Witkin JM and Li X: Curcumin, an active
constiuent of the ancient medicinal herb Curcuma longa L.: some
uses and the establishment and biological basis of medical
efficacy. CNS Neurol Disord Drug Targets. 12:487–497. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li Y and Zhang T: Targeting cancer stem
cells by curcumin and clinical applications. Cancer Lett.
346:197–205. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Prasad S, Gupta SC, Tyagi AK and Aggarwal
BB: Curcumin, a component of golden spice: from bedside to bench
and back. Biotechnol Adv. 32:1053–1064. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rahmani AH, Al Zohairy MA, Aly SM and Khan
MA: Curcumin: a potential candidate in prevention of cancer via
modulation of molecular pathways. Biomed Res Int. 2014:7616082014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Han SS, Chung ST, Robertson DA, Ranjan D
and Bondada S: Curcumin causes the growth arrest and apoptosis of B
cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-κB, and
p53. Clin Immunol. 93:152–161. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mukherjee Nee Chakraborty S, Ghosh U,
Bhattacharyya NP, Bhattacharya RK, Dey S and Roy M:
Curcumin-induced apoptosis in human leukemia cell HL-60 is
associated with inhibition of telomerase activity. Mol Cell
Biochem. 297:31–39. 2007. View Article : Google Scholar
|
|
38
|
Shishodia S, Chaturvedi MM and Aggarwal
BB: Role of curcumin in cancer therapy. Curr Probl Cancer.
31:243–305. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li J, Zhang D, Stoner GD and Huang C:
Differential effects of black raspberry and strawberry extracts on
BaPDE-induced activation of transcription factors and their target
genes. Mol Carcinog. 47:286–294. 2008. View
Article : Google Scholar
|
|
40
|
Coussens LM and Werb Z: Matrix
metalloproteinases and the development of cancer. Chem Biol.
3:895–904. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tsai CH, Chiang YC, Chen HT, Huang PH, Hsu
HC and Tang CH: High glucose induces vascular endothelial growth
factor production in human synovial fibroblasts through reactive
oxygen species generation. Biochim Biophys Acta. 1830:2649–2658.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu W, Sha X, Wen Y, Zhao W, Luo W and Hua
Z: Effect of Avastin on the migration and invasion of pterygium
fibroblasts. Eye Sci. 29:214–218. 2014.
|
|
43
|
Hosseini H, Nejabat M and Khalili MR:
Bevacizumab (Avastin) as a potential novel adjunct in the
management of pterygia. Med Hypotheses. 69:925–927. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bahar I, Yeung SN, Sella R and Slomovic A:
Anterior segment uses of bevacizumab. Curr Opin Ophthalmol.
23:303–316. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hu A, Huang JJ, Jin XJ, Li JP, Tang YJ,
Huang XF, Cui HJ, Xu WH and Sun GB: Curcumin suppresses
invasiveness and vasculogenic mimicry of squamous cell carcinoma of
the larynx through the inhibition of JAK-2/STAT-3 signaling
pathway. Am J Cancer Res. 5:278–288. 2014.
|
|
46
|
Sun ZJ, Chen G, Zhang W, Hu X, Liu Y, Zhou
Q, Zhu LX and Zhao YF: Curcumin dually inhibits both mammalian
target of rapamycin and nuclear factor-κB pathways through a
crossed phosphatidylinositol 3-kinase/Akt/IκB kinase complex
signaling axis in adenoid cystic carcinoma. Mol Pharmacol.
79:106–118. 2011. View Article : Google Scholar
|
